Vertex Pharmaceuticals (VRTX) Receives a Hold from Scotiabank
In a report released today, Greg Harrison from Scotiabank maintained a Hold rating on Vertex Pharmaceuticals (VRTX – Research Report), with a ...
Vertex Pharmaceuticals (VRTX) Initiated with a Buy at Cantor Fitzgerald
Vertex Pharmaceuticals (VRTX – Research Report) received a Buy rating and a $480.00 price target from Cantor Fitzgerald analyst Olivia Brayer ...
Vertex Pharmaceuticals' non-opioid pain medication gets FDA approval
A non-opioid pain medication made by Vertex Pharmaceuticals has received approval for adults from the Food and Drug ...
Vertex Pharmaceuticals Shares Are Up Today: What's Going On?
Vertex Pharmaceuticals Inc. (NASDAQ: VRTX) shares are trading higher Friday following two major developments that strengthen ...
Vertex Pharmaceuticals stock is soaring. The FDA just approved its potentially game-changing pain treatment.
Shares of Vertex Pharmaceuticals Inc. surged ahead of Friday’s market open after the Food and Drug Administration approved the company’s non-opioid pain treatment.
Investor's Business Daily on MSN4h
How Painkillers Could Be Vertex Pharmaceuticals' Next $10 Billion Chapter
Vertex Pharmaceuticals could soon capture $10 billion in sales of non-opioid painkillers, an analyst said Friday as Vertex stock jumped.
Wall St set to open higher on gains in Apple, in-line inflation reading
Wall Street's main indexes were set to open higher on Friday on gains in Apple following its strong sales forecast, with an ...
US open: Stocks jump on the back of slightly better-than-expected data
Wall Street was moving higher still shortly after the open, on the back of slightly better-than-expected readings for US ...
MarketWatch20h
Prologis Inc.
Link Parks Inc. Dep. Pfd. (Rep. 1/1000th 5.25% Cum. Redeem. Pfd. Series X) 0.91% Link Parks Inc. Dep. Pfd. (Rep. 1/1000th Share 4.875% Pfd. Series Z) 32.53% Link ...